BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38579099)

  • 21. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
    Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA
    Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative blood transfusion and the clinical outcomes of patients undergoing cholangiocarcinoma surgery: a systematic review and meta-analysis.
    Wang Q; Du T; Lu C
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1233-40. PubMed ID: 27560845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
    Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
    BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
    Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
    Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
    Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
    Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
    Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
    Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of blood transfusions on oncological outcomes of surgically treated localized renal cell carcinoma.
    Tsivian M; Abern MR; Tsivian E; Sze C; Jibara G; Rampersaud EN; Polascik TJ
    Urol Oncol; 2018 Aug; 36(8):362.e1-362.e7. PubMed ID: 29793797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Implication and Survival Outcomes of Perioperative Blood Transfusion on Urological Malignancies Undergoing Radical Surgical Intervention.
    Mallick S; Mallik M; Chowdhury PS
    Iran J Pathol; 2023; 18(1):33-48. PubMed ID: 37383156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Reduced Renal Function Predispose to Cancer-specific Mortality from Renal Cell Carcinoma?
    Palacios DA; Zabor EC; Munoz-Lopez C; Roversi G; Mahmood F; Abramczyk E; Kelly M; Wilson B; Abouassaly R; Campbell SC
    Eur Urol; 2021 Jun; 79(6):774-780. PubMed ID: 33678521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infectious complications associated with perioperative blood transfusion in partial or radical nephrectomy.
    Hamilton ZA; Carbonella J; Siddiqui S; Al-Hammadi N; Hinyard L
    Urol Oncol; 2021 Feb; 39(2):134.e17-134.e26. PubMed ID: 33250344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of individual and cumulative sites of extrarenal tumor invasion in pT3a clear cell renal cell carcinoma.
    Flood TA; Hogan K; Lavallée LT; Breau RH; Morash C; Belanger EC; Schieda N
    Urol Oncol; 2020 Feb; 38(2):42.e13-42.e18. PubMed ID: 31740333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Rink M; Soave A; Dahlem R; Aziz A; Al-Sayed F; Peine S; Engel O; Kluth LA; Stenzl A; Burger M; Shariat SF; Fisch M; Fritsche HM; Gakis G
    Clin Genitourin Cancer; 2016 Feb; 14(1):96-104. PubMed ID: 26506908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive factors for perioperative blood transfusions in partial nephrectomy for renal masses.
    Abu-Ghanem Y; Dotan Z; Kaver I; Ramon J
    J Surg Oncol; 2015 Oct; 112(5):496-502. PubMed ID: 26437866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation.
    Nocera L; Collà Ruvolo C; Stolzenbach LF; Wenzel M; Tian Z; Larcher A; Capitanio U; Mirone V; Tilki D; Chun FKH; Kapoor A; Shariat SF; Saad F; Montorsi F; Briganti A; Karakiewicz PI
    Eur Urol Focus; 2022 Jan; 8(1):182-190. PubMed ID: 33653677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Perioperative Blood Transfusion on Prognosis after Radical Resection in Patients with Non-Metastatic Renal Cell Carcinoma: A Retrospective Analysis.
    Zhang Y; Peng Y; Liu J; Jia C; Shen B; Wang R
    Arch Esp Urol; 2024 May; 77(4):412-417. PubMed ID: 38840285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma Patients.
    Scheipner L; Incesu RB; Morra S; Baudo A; Assad A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Tilki D; Longo N; Carmignani L; De Cobelli O; Pichler M; Ahyai S; Karakiewicz PI
    Clin Genitourin Cancer; 2024 Apr; 22(2):164-170. PubMed ID: 37981546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative blood transfusions for the recurrence of colorectal cancer.
    Amato A; Pescatori M
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD005033. PubMed ID: 16437512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perioperative Blood Transfusion Promotes Worse Outcomes of Bladder Cancer after Radical Cystectomy: A Systematic Review and Meta-Analysis.
    Wang YL; Jiang B; Yin FF; Shi HQ; Xu XD; Zheng SS; Wu S; Hou SC
    PLoS One; 2015; 10(6):e0130122. PubMed ID: 26080092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.